Leading cardiovascular physicians and researchers gathered at SHAPE Trial Advisory meeting to chart the course for perfecting early detection of patients vulnerable to heart attack (read more...)
***The SHAPE Trial Advisory Meeting, August 21-23, 2015, Los Angeles - Marina del Ray, CA***
Ritz-Carlton Hotel, Marina Vista Conference Room
Day 1: Necessity, Feasibility, Design, Implementation, and Fundraising for a Longitudinal Outcome Study to Compare SHAPE Guidelines with the Status Quo
Day 2: Public Healthcare Policies and Regulatory Initiatives, SHAPE Centers of Excellence
***Six Additional East Texas Medical Center Hospitals Certified as SHAPE Centers of Excellence***
***The SHAPE Accredited Centers of Excellence program is a scientifically validated and guideline-based approach to early detection of Coronary Artery Disease.***
View our SHAPE Videos:
The Society for Heart Attack Prevention & Eradication (SHAPE) is a tax-deductible 501(c)(3) nonprofit organization that promotes public and professional education for early detection of individuals with atherosclerotic plaques that are at risk of heart attacks and stroke but have no symptoms. These individuals who are unaware of their risk are often misclassified by traditional methods (measuring risk factors such as cholesterol and blood pressure). Sadly every year approximately 600,000 of these asymptomatic individuals in the US and millions worldwide lose their life to a sudden heart attack or stroke. SHAPE is committed to saving these lives by raising awareness of the need for screening to detect asymptomatic atherosclerosis.
SHAPE's mission is to eradicate heart attacks and stroke by championing new strategies for prevention while advancing the scientific quest for a cure such as vaccines for heart attack. Heart attacks and stroke can and should be eradicated in our lifetime.
SHAPE Applauds U.S Preventive Services Task Force for Seeking the Truth about Coronary Artery Calcium
Evidence is Clear that Preventive Screening Tests for Coronary Artery Calcium Can Prevent Heart Attacks
HOUSTON, June 24, 2015 – SHAPE, The Society for Heart Attack Prevention and Eradication (http://www.shapesociety.org), a nonprofit grassroots organization dedicated to the mission of eradicating heart attacks, today submitted a letter to the U.S. Preventive Services Task Force (USPSTF) strongly supporting the use of coronary artery calcium to assess an individual’s risk of heart attack. The USPSTF is currently accepting public comment for its “Draft Research Plan for Cardiovascular Disease: Risk Assessment Using Nontraditional Risk Factors.” Coronary artery calcium is among the nontraditional risk factors being considered.
Traditional risk assessment methods that rely solely on the Framingham Risk Score have proven to be suboptimal, as evidenced by the fact that 525,000 Americans suffer a first heart attack annually, according to the Centers for Disease Control and Prevention. Had they been evaluated the day before their heart attack by the traditional risk assessment method (Framingham Risk Score which relies on age sex, cholesterol blood pressure, smoking, etc.) the majority would fall in the Low to Intermediate Risk categories. This is unacceptable.
SHAPE advocates using non-invasive screening tests to determine an individual’s coronary artery calcium score. The approach is modeled after successful screening protocols for breast and colorectal cancers once women and men reach a certain age.
“By relying on traditional risk assessment, many high risk and “vulnerable patients” are left unaware or inadequately treated, and many low risk individuals are inappropriately targeted for treatment, which burdens our healthcare system,” stated the SHAPE letter. The letter was signed by the Chairwoman of the SHAPE Board of Directors, JoAnne Zawitoski, SHAPE Scientific Chairman, P.K. Shah, M.D. and the founder of SHAPE and Executive Chairman of the SHAPE Task Force, Morteza Naghavi, M.D.
SHAPE urged the USPSTF to review the work of the SHAPE Task Force, which has explored the advantages and limitations of various traditional and nontraditional methods of assessing risk of heart attack. This work, stretching back more than a decade, has included 15 scientific symposia and over 50 scientific publications on the topic the USPSTF is now examining.
The USPSTF is an independent, volunteer panel of national experts in prevention and evidence-based medicine that works to improve the health of all Americans by making evidence-based recommendations about clinical preventive services such as screenings, counseling services and preventive medications.
Based in Houston, the Society for Heart Attack Prevention and Eradication (SHAPE) is a non-profit organization that promotes education and research related to prevention, detection, and treatment of heart attacks. SHAPE is committed to raising public awareness about revolutionary discoveries that are opening exciting avenues to prevent heart attacks. SHAPE's mission is to eradicate heart attacks in the 21st century. Additional information is available on the organization's Web site at www.shapesociety.org.
About SHAPE Task Force
The SHAPE Task Force, an international group of leading cardiovascular physicians and researchers, has created the SHAPE Guidelines, which educates physicians how to identify asymptomatic atherosclerosis (hidden plaques) and implement proper therapies to prevent a future heart attack. According to the SHAPE Guidelines, individuals with high risk atherosclerosis (high plaque score) should be treated even if their cholesterol level is within the so called “normal range.” Knowing one's plaque score can be a matter of life and death. Additional information is available by calling 1-877-SHAPE11. And additional information is available at http://www.shapesociety.org.
The SHAPE Task Force includes the following:
Morteza Naghavi, M.D. – Executive Chairman
PK Shah, M.D. – Chair of Scientific Board
Erling Falk, M.D., Ph.D. – Chief of Editorial Committee
SHAPE Task Force Members (alphabetic order): Arthur Agatston, M.D., Daniel S. Berman, M.D., Matthew J. Budoff, M.D., Raimund Erbel, M.D., Erling Falk, M.D., Ph.D., Sergio Fazio, M.D., Ph.D., Steven B. Feinstein, M.D., Craig Hartley, Ph.D., Harvey S. Hecht, M.D., Howard Hodis, M.D., Ioannis Kakadiaris, Ph.D., Sanjay Kaul, M.D., M.P.H., Asher Kimchi. M.D., Wolfgang Koenig, M.D., Ph.D., Iftikhar J. Kullo, M.D., Daniel Lane, M.D., Ph.D., Roxana Mehran, M.D., Ralph Metcalfe, Ph.D., Morteza Naghavi, M.D., Tasneem Z. Naqvi, M.D., Jagat Narula, M.D., Paolo Raggi, M.D., George P. Rodgers, M.D., James HF Rudd, Ph.D., Robert S. Schwartz, M.D., PK Shah, M.D., Leslee Shaw, M.D., David Spence, M.D., H. Robert Superko, M.D., Henrik Sillesen, M.D., Ph.D., Pierre-Jean Touboul, M.D.
Distinguished SHAPE Task Force Advisor: Valentin Fuster, M.D., Ph.D.
Chair of SHAPE Board of Directors: JoAnne Zawitoski, J.D.
SHAPE Task Force Public Relations: Daniel Keeney
Executive Director of SHAPE Centers of Excellence: Jeff Fine, Ph.D.
SHAPE Board Executive Secretary: Brenda Garrett Superko, CVRN
SHAPE Task Force Applauds Recent Urgent Calls to Overhaul CVD Prevention Guidelines
THE HEART ATTACK ERADICATION SOCIETY URGES DOCTORS TO ADOPT PERSONALIZED RISK ASSESSMENT
HOUSTON, TEXAS, November 14, 2014 – Leading preventive cardiologists and academic cardiovascular specialists from the Society for Heart Attack Prevention and Eradication (SHAPE), a non-profit organization advocating for early detection of future heart attack victims, endorse and applaud Dr. Steven Nissen’s urgent call to improve upon the existing inaccurate guidelines for detection and prevention of cardiovascular disease.
“We are delighted to hear Dr. Nissen and other well established physicians in the cardiology community call for revising existing guidelines” said Dr. PK. Shah, Chairman of SHAPE Scientific Advisory Board. “As many of you know, we have raised flags repeatedly since 2005 when we announced the SHAPE Guidelines and are looking forward to the much needed overhaul”.
Infographic Shows The Differences Between The Diseases We Donate To, And The Diseases That Kill Us
Primary Prevention of Atherosclerotic Cardiovascular Disease:
Noninvasive Screening - Polypill Therapy - Vaccination
Once again MESA confirms SHAPE
"These findings, combined with the results of our analysis, suggest that CAC may be useful in determining the potential benefit of both aspirin and statin therapy, thus increasing the use of CAC as a tool for improved clinical decision making," authors write. Heartwire."
This is what SHAPE Task Force recommended about 10yrs ago. Read more.
SHAPE Observes First "Texas Blood Pressure Day" Event by Urging Everyone to Check for High Blood Pressure Regularly
High blood pressure (hypertension) is a serious condition that, if untreated, can worsen over time, leading to coronary heart disease, heart failure, aneurysms, stroke and kidney failure.
HOUSTON, TX - August 26, 2013 - Approximately one in three adults in the United States has high blood pressure and more than 20% don't even know they have it. Known as the silent killer, there are often no symptoms until the heart, arteries, and other organs are already damaged. And because of the obesity epidemic, more and more children are developing high blood pressure at earlier and earlier ages.
SHAPE Advisor, Dr. Valentin Fuster Named Editor Of The Journal Of The American College Of Cardiology
SHAPE applauds the American College of Cardiology's decision to appoint Dr. Fuster to be the next editor-in-chief of the JACC, its acclaimed peer-reviewed publication.
(PRWEB) August 21, 2013 - The Society for Heart Attack Prevention and Eradication (SHAPE) is pleased to congratulate Dr. Valentin Fuster, renowned cardiologist and scientific investigator, on being named the next editor-in-chief of the Journal of the American College of Cardiology (JACC). He will succeed the current editor, Anthony DeMaria, M.D., beginning in 2014.